Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Monday’s key moments. 1. U.S. stocks were modestly higher Monday as the market awaits key economic data. Traders will be mulling over the consumer price index Tuesday, retail sales Thursday, and the producer price index Friday. These are some of the closely watched gauges that the Federal Reserve takes into account when deciding when to start and how much to cut interest rates this year. Jim Cramer said Monday equities are in a “flop and chop mode” following record highs from the S & P 500 and the Dow . The market’s been up 14 out of the past 15 weeks, so it’s hard for investors to justify buying at these levels. 2. Wall Street sees even more upside for Nvidia . Melius Research boosted the company’s two-year price target to $920 per share from $750 — nearly 28% upside from Friday’s close. The analysts compared Nvidia’s surging demand and success back to the early days of Apple’s iPhone. “An investor once asked us in 2007, ‘Won’t every person need an iPhone?’ Another recently asked us ‘Won’t every server need to be accelerated? ‘The answer to each is a ‘yes’, which underpins strong growth through 2030,” the analysts wrote. Jim agreed. Nvidia stock was up more than 3% to another all-time high Monday. 3. UBS boosted its GE Healthcare price target to $88 per share from $66 and upgraded its rating to neutral from sell. The analysts cited the company’s recent upbeat quarterly. This is a big change of tone for UBS analysts, who slashed the medical equipment maker’s rating to sell in November on management’s alleged inability to hit margin targets. We never understood this call and always thought the company’s integration of AI into its products, which include MRI, CT, and ultrasound machines would be highly beneficial. (Jim Cramer’s Charitable Trust is long NVDA, GEHC, AAPL . See here for a full list of the stocks.) As a subscriber to the…
Read the full article here
